Literature DB >> 23695505

When is the use of aspirin for CVD prevention in women appropriate?

Joann E Manson1, Shari S Bassuk.   

Abstract

Women age 65 and older without known cardiovascular disease (CVD), women of any age with established CVD, and women of any age with an estimated 10-year risk of CVD ≥10%, are likely to experience a net benefit from preventive low-dose aspirin therapy and should be considered for such therapy unless contraindicated.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 23695505     DOI: 10.1097/GME.0b013e318298d74e

Source DB:  PubMed          Journal:  Menopause        ISSN: 1072-3714            Impact factor:   2.953


  2 in total

1.  Risk factors of in-hospital mortality among patients with upper gastrointestinal bleeding and acute myocardial infarction.

Authors:  Lingjie He; Jianwei Zhang; Shutian Zhang
Journal:  Saudi J Gastroenterol       Date:  2018 May-Jun       Impact factor: 2.485

2.  Upper gastrointestinal bleed in a post menopausal woman due to combination of high first dose aspirin and clopidogrel prescribed for acute coronary syndrome.

Authors:  Vishal R Tandon; Rubeena Maqbool; Iram Kahkashan; Rashmi Sharma; Vijay Khajuria; Zahid Gillani
Journal:  J Midlife Health       Date:  2015 Jul-Sep
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.